Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(26 sites)
United States
Dr. Falk Investigational Site, Scottsdale, Arizona Dr. Falk Investigational Site, Little Rock, Arkansas Dr. Falk Investigational Site, La Jolla, California Dr. Falk Investigational Site, Lomita, California Dr. Falk Investigational Site, San Diego, California Dr. Falk Investigational Site, Doral, Florida Dr. Falk Investigational Site, New Port Richey, Florida Dr. Falk Investigational Site, Boise, Idaho Dr. Falk Investigational Site, Houma, Louisiana Dr. Falk Investigational Site, Marrero, Louisiana Dr. Falk Investigational Site, Boston, Massachusetts Wyoming, Ann Arbor, Michigan Dr. Falk Investigational Site, Wyoming, Michigan Dr. Falk Investigational Site, Rochester, Minnesota Dr. Falk Investigational Site, Freehold, New Jersey Dr. Falk Investigational Site, Jackson, New Jersey Dr. Falk Investigational Site, New York, New York Dr. Falk Investigational Site, Chapel Hill, North Carolina Dr. Falk Investigational Site, Cleveland, Ohio Dr. Falk Investigational Site, Mentor, Ohio Wyoming, Philadelphia, Pennsylvania Dr. Falk Investigational Site, Harlingen, Texas Dr. Falk Investigational Site, Salt Lake City, Utah Dr. Falk Investigational Site, Charlottesville, Virginia Dr. Falk Investigational Site, Lynchburg, Virginia Spain
Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso